4.3 Article

Identification of a novel non-coding mutation in C1qB in a Dutch child with C1q deficiency associated with recurrent infections

Journal

IMMUNOBIOLOGY
Volume 220, Issue 3, Pages 422-427

Publisher

ELSEVIER GMBH, URBAN & FISCHER VERLAG
DOI: 10.1016/j.imbio.2014.10.005

Keywords

Autoimmunity; Complement; C1q deficiency; Infections; Mutation; Primary immunodeficiency

Categories

Funding

  1. European Union [Health-F2-2008-223404]
  2. IMI JU [115142-2]
  3. Netherlands Genomics Initiative (NGI) as part of the Netherlands Proteomics Center (NPC: II T5.1)
  4. VIDI-Grant from NWO-Zon-MW [016.126.334]
  5. VICI-Grant from NWO-Zon-MW [918.96.606]
  6. European Community [PIOF-GA-2009-237280]

Ask authors/readers for more resources

Introduction: C1q deficiency is a rare genetic disorder that is strongly associated with development of systemic lupus erythematosus (SLE). Several mutations in the coding regions of the C1q genes have been described that result in stop-codons or other genetic abnormalities ultimately leading to C1q deficiency. Here we report on a Dutch boy suffering from recurrent infections with a complete C1q deficiency, without any SLE symptoms. Methods: The presence of C1q in serum was assessed using ELISA and hemolytic assay. By western blot we examined the different C1q chains in celllysates. We identified the mutation using deep-sequencing. By qPCR we studied the mRNA expression of C1qA, C1qB and C1qC in the PBMCs of the patient. Results: Deep-sequencing revealed a homozygous mutation in the non-coding region of C1qB in the patient, whereas both parents were heterozygous. The mutation is located two nucleotides before the splice site of the second exon. In-silico analyses predict a complete abrogation of this natural splice site. Analyses of in vitro cultured cells from the patient revealed a lack of production of C1q and intracellular absence of C1qB in the presence of C1qA and C1qC peptides. Quantitative PCR analysis revealed total absence of C1qB mRNA, a reduced level of C1qA mRNA and normal levels of C1qC mRNA. Conclusion: In this study we report a new mutation in the non-coding region of C1qB that is associated with C1q deficiency. (C) 2014 Elsevier GmbH. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Biochemistry & Molecular Biology

The VEGF Inhibitor Soluble Fms-like Tyrosine Kinase 1 Does Not Promote AKI-to-CKD Transition

Cleo C. L. van Aanhold, Angela Koudijs, Kyra L. Dijkstra, Ron Wolterbeek, Jan A. Bruijn, Cees van Kooten, Hans J. Baelde

Summary: The study found that transfection with sFLT1 did not aggravate renal fibrosis and peritubular capillary loss, but reduced the expression of pro-fibrotic and pro-inflammatory markers. sFLT1 mRNA levels were not correlated with interstitial fibrosis or PTC loss in human samples.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Review Rheumatology

Glycobiology of rheumatic diseases

Theresa Kissel, Rene E. M. Toes, Thomas W. J. Huizinga, Manfred Wuhrer

Summary: Glycosylation is a common modification that affects protein stability and interactions. It plays a significant role in rheumatic diseases, influencing inflammatory processes and disease progression. Understanding the impact of glycosylation on plasma proteins, cells, and tissues opens up potential interventions for the treatment of these diseases.

NATURE REVIEWS RHEUMATOLOGY (2023)

Article Multidisciplinary Sciences

Host biomarker-based quantitative rapid tests for detection and treatment monitoring of tuberculosis and COVID-19

Louise Pierneef, Anouk van Hooij, Danielle de Jong, Elisa M. Tjon Kon Fat, Krista E. van Meijgaarden, Elisa Petruccioli, Valentina Vanini, Anna H. E. Roukens, Delia Goletti, Paul L. A. M. Corstjens, Simone A. Joosten, Annemiek Geluk, BEAT COVID Study Grp

Summary: Diagnostic services for TB and COVID-19 are not easily accessible in low-resource settings. This study demonstrates the potential of non-sputum lateral flow assays as adjunct diagnostics and treatment monitoring for both diseases based on quantitative detection of multiple host biomarkers.

ISCIENCE (2023)

Article Rheumatology

Progression from suspected to definite systemic sclerosis and the role of anti-topoisomerase I antibodies

Sophie I. E. Liem, Sam Neppelenbroek, Cynthia M. Fehres, Brigitte A. Wevers, Rene E. M. Toes, Cornelia F. Allaart, Tom W. J. Huizinga, Hans Ulrich Scherer, Jeska K. De Vries-Bouwstra

Summary: Early diagnosis of systemic sclerosis (SSc) is important. The most frequent SSc-specific autoantibodies are anti-centromere antibodies (ACA) and anti-topoisomerase I antibodies (ATA). ATA is associated with severe disease course. More detailed characterisation of the ATA-response in SSc might improve prognostication.

RMD OPEN (2023)

Article Rheumatology

Added value of multiple autoantibody testing for predicting progression to inflammatory arthritis in at-risk individuals

Frederique Ponchel, Laurence Duquenne, Xuanxiao Xie, Diane Corscadden, Farag Shuweihdi, K. Mankia, L. A. Trouw, Paul Emery

Summary: In this study, the researchers performed multiple autoantibody analysis to predict and determine the time of progression to inflammatory arthritis (IA). The results showed that multiple autoantibody testing provided added value and allowed for more specific stratification in identifying progressors to clinical disease for intervention studies.

RMD OPEN (2022)

Letter Rheumatology

IgM antibodies against acetylated proteins as a possible starting point of the anti-modified protein antibody response in rheumatoid arthritis

Tineke J. van Wesemael, Sanne Reijm, Atsushi Kawakami, Annemarie L. Dorjee, Gerrie Stoeken, Takahiro Maeda, Shin-ya Kawashiri, Tom W. J. Huizinga, Mami Tamai, Rene E. M. Toes, Diane van der Woude

ANNALS OF THE RHEUMATIC DISEASES (2023)

Article Immunology

Addressing the key issue: Antigen-specific targeting of B cells in autoimmune diseases

Miles D. Holborough-Kerkvliet, Sanne Kroos, Renee van de Wetering, Rene E. M. Toes

Summary: Autoimmune diseases are characterized by a breakdown of immunological tolerance to self, resulting in an abnormal immune response to self-antigens. The pathogenesis is driven by a complex interaction between autoreactive B and T cells. B cell targeting therapies, such as Rituximab, have shown efficacy in reducing symptoms of autoimmune diseases, but can also lead to infections. Therefore, antigen-specific approaches to target autoreactive cells are being investigated.

IMMUNOLOGY LETTERS (2023)

Article Multidisciplinary Sciences

Complement is activated by elevated IgG3 hexameric platforms and deposits C4b onto distinct antibody domains

Leoni Abendstein, Douwe J. Dijkstra, Rayman T. N. Tjokrodirijo, Peter A. van Veelen, Leendert A. Trouw, Paul J. Hensbergen, Thomas H. Sharp

Summary: The authors used cryoEM and MS techniques to investigate IgG3-mediated complement activation and provide the first structural insights into IgG3. IgG3 is distinct from other IgG subclasses due to its extended hinge, allotypic diversity, and enhanced effector functions. However, the lack of structural information has limited its use as an immunotherapeutic candidate.

NATURE COMMUNICATIONS (2023)

Article Medicine, Research & Experimental

Autoreactive B cells in rheumatoid arthritis include mainly activated CXCR3+memory B cells and plasmablasts

Sanne Reijm, Joanneke C. Kwekkeboom, Nienke J. Blomberg, Jolien Suurmond, Diane van der Woude, Rene E. M. Toes, Hans U. Scherer

Summary: This study visualizes the B cell response against posttranslational modification antigens in autoimmune diseases. The results demonstrate extensive cross-reactivity of B cells against different antigens and the presence of PTM-directed plasmablasts in patients. The expression of CXCR3 suggests the potential involvement of chemokines in this process.

JCI INSIGHT (2023)

Article Rheumatology

Anti-topoisomerase, but not anti-centromere B cell responses in systemic sclerosis display active, Ig-secreting cells associated with lung fibrosis

Corrie M. Wortel, Sophie I. E. Liem, Nina M. van Leeuwen, Maaike Boonstra, Cynthia M. Fehres, Lauran Stoeger, Tom W. J. Huizinga, Rene E. M. Toes, Jeska De Vries-Bouwstra, Hans U. Scherer

Summary: This study investigates the autoreactive B cell responses in ATA-positive and ACA-positive SSc patients. The results show that ATA-positive patients exhibit a more active B cell response, which is associated with the presence and severity of ILD. This may explain the differential responsiveness to B cell depleting therapy.

RMD OPEN (2023)

Article Immunology

At Critically Low Antigen Densities, IgM Hexamers Outcompete Both IgM Pentamers and IgG1 for Human Complement Deposition and Complement-Dependent Cytotoxicity

Nienke Oskam, Pleuni Ooijevaar-de Heer, Ninotska I. L. Derksen, Simone Kruithof, Steven W. de Taeye, Gestur Vidarsson, Sanne Reijm, Theresa Kissel, Rene E. M. Toes, Theo Rispens

Summary: This study systematically investigated human IgM-mediated complement activation and found that hexameric IgM outperformed pentameric IgM and IgG1 in complement activation at low antigen densities, highlighting the importance of IgM in immunity.

JOURNAL OF IMMUNOLOGY (2022)

Article Medical Laboratory Technology

Multiplex LC-MS/MS Testing for Early Detection of Kidney Injury: A Next-Generation Alternative to Conventional Immunoassays?

Tirsa T. van Duijl, L. Renee Ruhaak, Cees van Kooten, Johan W. de Fijter, Christa M. Cobbaert

Summary: This study explored the potential of LC-MS/MS as a next-generation technology for multiplex urinary protein measurement. It overcomes nonselectivity and lack of standardization by directly measuring well-defined molecular proteins.

JOURNAL OF APPLIED LABORATORY MEDICINE (2022)

Article Gastroenterology & Hepatology

B-cell activating factor and IL-21 levels predict treatment response in autoimmune hepatitis

Maaike Biewenga, Sebastiaan Heidt, Manon Vergunst, Camiel M. J. Marijnissen, Rob A. de Man, Annemiek A. van der Eijk, Adriaan J. van der Meer, Leendert A. Trouw, Bart van Hoek

Summary: This study assessed the levels of B cell activating factor of the tumour necrosis family (BAFF), IL-21, and circulating B cell populations in patients with autoimmune hepatitis (AIH) and identified different immunological phenotypes. Patients in the high IL-21 group had the poorest treatment response and a risk of developing PSC variant syndrome.

JHEP REPORTS (2022)

Article Immunology

Circulating Levels of Anti-C1q and Anti-Factor H Autoantibodies and Their Targets in Normal Pregnancy and Preeclampsia

Douwe Jan Dijkstra, A. Inkeri Lokki, Lobke Marijn Gierman, Nicole Veronique Borggreven, Carin van der Keur, Michael Eikmans, Kyra Andrea Gelderman, Hannele Laivuori, Ann-Charlotte FINNPEC Core Investigator Grp, Ann-Charlotte Iversen, Marie-Louise P. van der Hoorn, Leendert Adrianus Trouw

Summary: Preeclampsia (PE) may be associated with decreased levels of C1q and FH, which are related to placental dysfunction and immune response.

FRONTIERS IN IMMUNOLOGY (2022)

Meeting Abstract Biochemistry & Molecular Biology

Circulating levels of anti-C1q and anti-Factor H autoantibodies and their targets in preeclampsia

Douwe Dijkstra, Inkeri Lokki, Lobke Gierman, Nicole Borggreven, Carin van der Keur, Hannele Laivuori, Finnpec Board, Ann-Charlotte Iversen, Marie van der Hoorn Louise, Leendert Trouw

MOLECULAR IMMUNOLOGY (2022)

No Data Available